Navigation Links
NIH launches Phase I clinical trial of novel drug to treat Clostridium difficile infection
Date:7/9/2014

tigational drug; 2 participants will receive a placebo pill). In the first group, participants will receive either 200 milligrams (mg) of CRS3123 or placebo twice daily for 10 days. Based on the review of safety data from this group, the study will progress to a second and then a third group of volunteers with a maximum possible dose of 600 mg twice daily. Participation in the trial will require an inpatient stay of 12 days to allow for monitored dosing and physical evaluations, including blood tests and urinalysis. Participants will be evaluated on an outpatient basis 18 and 29 days after receiving the first dose of the investigational drug. The study is expected to be completed by March 2015.


'/>"/>
Contact: Jennifer Routh
jennifer.routh@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. IntegraGen launches ARISk test, a genetic screening tool for autism in high-risk children
2. Mayo Clinic launches whole genome breast cancer study
3. Original research papers on acute cardiovascular care: ESC launches EHJ-ACVC
4. UCLA launches first face transplantation program in western US
5. Georgia Tech launches HomeLab to help companies evaluate home health technologies
6. US Drug Watchdog Launches Now Calls Transvaginal Mesh A Disaster For 100,000's of US Women Recipients And Offers The Names and Contacts Of The Best Women Attorneys
7. K9 CarFence™ Launches as Newest Innovation in Pet Transportation
8. Golden Gate Opportunity: Moravia Worldwide Launches Bay Area Operation
9. 'Music Makes It Better' Campaign Launches with Justin Bieber, Victoria Justice, and The Band Perry
10. Fieldtex Products Launches a New Wellness Rewards Service for Companies
11. Recruiting for Good Launches Pet Philanthropy Program to Collaboratively Fundraise for Kitt Crusaders an Animal Rescue Organization
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
NIH launches Phase I clinical trial of novel drug to treat Clostridium difficile infection
(Date:7/31/2015)... ... July 31, 2015 , ... Coco Libre announced today that ... and VIPs at the 2015 Vans US Open of Surfing, July 25 through August ... claim “no added sugar” on the market, is a natural choice given the Open’s ...
(Date:7/31/2015)... York, NY (PRWEB) , ... July 31, 2015 , ... ... Rodgers Theatre . Those looking to catch a new and refreshing show on ... won numerous awards and achievements including an Obie Award, Outer Critics Circle Award, Drama ...
(Date:7/31/2015)... Angeles, CA (PRWEB) , ... July 31, 2015 , ... ... surgeons and cosmetic experts gathered to see if they could reach a consensus on ... including breast augmentation and facelifts. Overall, the group reached 90 percent consensus on a ...
(Date:7/31/2015)... York, New York (PRWEB) , ... ... ... renowned trial attorney Jason T. Brown’s live lecture on pharmaceutical negligence is ... July 28th, 2015 was well received with a 94% approval rating from ...
(Date:7/31/2015)... ... July 31, 2015 , ... As part of their ... involvement and support of animal welfare organizations is essential to the longevity of their ... year in the National Association of Professional Pet Sitters (NAPPS) annual Presents 4 Pets ...
Breaking Medicine News(10 mins):Health News:Coco Libre Brings Eco-conscious Hydration to Vans US Open of Surfing 2Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 2Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 3Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 4Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 5Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 6Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 7Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 2Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 3Health News:Re-Broadcast of Nationally Renowned Trial Attorney Jason T. Brown's Lecture on Pharmaceutical Negligence Now Available 2Health News:Dallas-based Park Cities Pet Sitter Selects Non-Profit Animal Welfare Organization “Angie’s Friends” as this Year’s Recipient of their Presents 4 Pets Supply Drive. 2Health News:Dallas-based Park Cities Pet Sitter Selects Non-Profit Animal Welfare Organization “Angie’s Friends” as this Year’s Recipient of their Presents 4 Pets Supply Drive. 3Health News:Dallas-based Park Cities Pet Sitter Selects Non-Profit Animal Welfare Organization “Angie’s Friends” as this Year’s Recipient of their Presents 4 Pets Supply Drive. 4
... Advisors LLC, on behalf of,the HealthShares(TM) family of ... Parkinson,s Disease Foundation (PDF), a leading,national presence in ... platinum level support of the PDF 50th Anniversary ... Quality of Life,and exclusive support of the symposium ...
... NEW YORK, Oct. 10 HealthShares(TM) Inc., an investment,company ... its Board of,Directors has approved the transfer of its ... Arca trading platform,in accordance with NYSE Euronext requirement to ... The transfer is expected to be completed prior to,October ...
... SpectraScience, Inc. (OTC,Bulletin Board: SCIE) announced today that ... the Company,s quality system from the Notified,Body G-MED. ... to,Annex II.3 of the European directive 93/42/EEC. In ... Jim Hitchin the Company,s CEO said, "This ...
... controls how stem cells choose to become either skeletal ... that support blood vessels, according to a study published ... Sciences (PNAS). The results not only provide insight ... fetus, but also suggest new ways to treat atherosclerosis ...
... PartsSource, the nation,s leading,supplier of replacement medical parts ... Growth award for Northern Ohio for the,second year ... honors,companies for outstanding growth and overall contributions to ... have our patented PartsFinder application recognized,by this fine ...
... BEACH, Va., Oct. 10 AMERIGROUP,Corporation (NYSE: ... its earnings,for the third quarter ended September 30, ... 2007. At 9:30 a.m. Eastern Time on Thursday, ... call and webcast,to discuss earnings and other information. ...
Cached Medicine News:Health News:XShares Supports Parkinson's Disease Foundation 50th Anniversary Educational Symposium 2Health News:XShares Supports Parkinson's Disease Foundation 50th Anniversary Educational Symposium 3Health News:XShares Supports Parkinson's Disease Foundation 50th Anniversary Educational Symposium 4Health News:XShares Group LLC to Begin the Transfer of HealthShares(TM) NYSE-Listed ETFs to NYSE Arca 2Health News:XShares Group LLC to Begin the Transfer of HealthShares(TM) NYSE-Listed ETFs to NYSE Arca 3Health News:XShares Group LLC to Begin the Transfer of HealthShares(TM) NYSE-Listed ETFs to NYSE Arca 4Health News:SpectraScience Receives Final European Certification 2Health News:Study reveals how stem cells decide to become either skeletal or smooth muscle 2Health News:Study reveals how stem cells decide to become either skeletal or smooth muscle 3Health News:Study reveals how stem cells decide to become either skeletal or smooth muscle 4Health News:Study reveals how stem cells decide to become either skeletal or smooth muscle 5Health News:AMERIGROUP Corporation to Discuss Third Quarter Earnings on October 25 2
(Date:7/31/2015)... July 31, 2015 More than 1,500 substance ... will convene in Indianapolis Aug. ... 2015 Mid-Year Training Institute . The week-long training, held ... address one of our nation,s biggest public health challenges ... Training Institute is a one-of-a-kind intensive training opportunity, offering ...
(Date:7/31/2015)... , July 31, 2015 The Physician-Patient ... release on July 28, 2015, "Surviving Your Hospital ... Fundraising for Patient Safety." A sentence ... should read: "PPAHS is a member ... on Opioids. For more information on the National Coalition ...
(Date:7/31/2015)... , July 31, 2015  Xcelience, a contract ... it has made a structured cash investment in ... specializing in milling, micronization and powder size classification ... grow Powdersize,s business while simultaneously adding a complete ... portfolio of capabilities. "As we ...
Breaking Medicine Technology:Community Leaders From Across The Country Head To Indianapolis For CADCA 2015 Mid-Year Training Institute Aug. 2-6 2Xcelience Makes Structured Cash Investment in Powdersize 2Xcelience Makes Structured Cash Investment in Powdersize 3
... NEW YORK, Feb. 4, 2011 WebMD Health Corp. (Nasdaq: ... and CEO, will deliver a presentation at the UBS 21st ... at 12:00 p.m. ET. Investors, analysts and the ... broadcast of the presentation over the Internet.  The broadcast can ...
... Aethlon Medical, Inc., (OTC Bulletin Board: AEMD ... Joyce has issued the following letter to shareholders. ... Shareholders: Contrary to the value reflected in our ... enterprise. We have created an expansive technology platform that provides ...
Cached Medicine Technology:Aethlon Medical Releases Shareholder Letter 2Aethlon Medical Releases Shareholder Letter 3Aethlon Medical Releases Shareholder Letter 4
... neurostimulator equipped with a battery that can ... FDA approved battery life. It is the ... is helpful to people who require stronger ... RESTOREADVANCED and PRIMEADVANCED different from earlier generations ...
... tubes are heparinized glass capillary ... film. These tubes are used ... blood samples for the measurement ... electrolytes (excluding lithium) and can ...
... is an all-natural biologic implant derived from ... using the proven Tutoplast process with over ... cellular components. It can be used ... repair cases where a synthetic prostheses is ...
...
Medicine Products: